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Transport Proteins in Mammary Epithelial Cells  
Abstract 
Transporters localized in membranes of secreting mammary epithelial cells are 
involved in delivery of essential nutrients into milk. However, drugs and other 
xenobiotics may be substrates of these transporters and thus be actively secreted into 
milk, which may pose a health threat to breastfed infants and dairy consumers.  
Aims of the thesis were to determine expressions of drug transporters in mammary 
gland tissue and to assess mammary cell models for studies of these proteins. Gene 
expressions of members of the ABC (BCRP/ABCG2, MDR1/ABCB1, MRP1/ABCC1) 
and SLC (OATP1A2/SLCO1A2, OCTN1/SLC22A4, OCT1/SLC22A1) families were 
measured in murine and bovine mammary tissue and in murine (HC11) and bovine 
(BME-UV) mammary epithelial cell lines.  
BCRP function was assessed by transport experiments with mitoxantrone (MX) in 
HC11 cells. Effects of the imidazole fungicide prochloraz on transporter expression and 
function in HC11 and BME-UV cells were examined. Expressions of BCRP and OCT1 
in murine mammary glands were increased during gestation and lactation, whereas 
MDR1, MRP1, OATP1A2 and OCTN1 were decreased, compared to expression in 
virgins. All transporters measured in mammary glands of mice were detected in bovine 
mammary tissue. All transporters investigated in vivo were also detected in HC11 cells, 
while only MDR1 and MRP1 were detected in BME-UV cells. Differentiation of HC11 
cells resulted in increased BCRP protein expression, while MDR1 expression was 
reduced. The BCRP inhibitor elacridar reduced secretion and increased accumulation of 
MX in both undifferentiated and differentiated HC11 cells. An increased accumulation 
of MX was observed in BCRP gene silenced HC11 cells. Prochloraz treatment induced 
MDR1 gene expression and protein function in both differentiated HC11 and BME-UV 
cells, resulting in decreased accumulation of the MDR1 substrate digoxin.  
In conclusion, we demonstrated that the HC11 and BME-UV mammary cell models 
are valuable tools for identifying substrates, inhibitors and inducers of transport 
proteins expressed in the mammary epithelium during lactation. The models can be 
used both to examine if chemical compounds are actively transported into milk and if 
they disrupt the normal function of transporters which may result in a disturbed 
delivery of essential nutrients into milk. 
Keywords: active transport, mammary epithelial, HC11 cells, BME-UV cells, RNAi, 
milk, lactation, ABC-transporters, SLC-transporters  
Author’s address: Yagmur Yagdiran, SLU, Department of Biomedical Sciences and 
Veterinary Public Health, P.O. Box 7028, 750 07 Uppsala, Sweden  
E-mail: Yagmur.Yagdiran@ slu.se 
 To the memory of my beloved father… 
 
 
 
 
 
 
 
Dünyada her şey için, medeniyet için, hayat için, başarı için, en hakiki mürşit 
bilimdir, fendir.   
   Mustafa Kemal Atatürk  
 Contents 
List of Publications 7 
Abbreviations 9 
1 Introduction 11 
1.1 Milk and environmental toxicants 11 
1.2 Mammary gland as a secretory organ 12 
1.3 Passive and active transport by several transport pathways 12 
1.3.1 Secretion routes 12 
1.3.2 Factors influencing chemical transfer into milk 13 
1.4 Transporters 13 
1.4.1 ATP-binding cassette (ABC) transporters 14 
1.4.2 Solute Carrier (SLC) Transporters 16 
1.5 Murine (HC11) and bovine (BME-UV) mammary epithelial cell            
lines as in vitro models 21 
2 Aims of the thesis 23 
3 Materials and Methods 25 
3.1 Chemicals 25 
3.2 Experimental models 25 
3.2.1 Mice 25 
3.2.2 The HC11 murine mammary epithelial cells (papers I and II) 25 
3.2.3 The BME-UV bovine mammary epithelial cells (paper II) 26 
3.3 Experimental Techniques 26 
3.3.1 Cellular organization of HC11 cells (paper I) 26 
3.3.2 Histological characterization of mammary gland                    
tissues of mice 26 
3.3.3 Cytotoxicity 26 
3.3.4 Gene expression 26 
3.3.5 Protein expression 27 
3.3.6 Gene silencing by small interfering RNAs (paper I) 27 
3.3.7 Transport Experiments (papers I and II) 27 
3.4 Statistics 28 
4 Results and Discussion 29 
4.1 Histology 29 
4.1.1 Mammary gland development in mouse (paper II) 29 
4.1.2 Cellular organization of HC11 cells (paper I) 30 
4.2 Induction of β-casein gene expression (papers I and II) 30 
4.3 Expressions of transporters (papers I and II) 31 
4.3.1 In vivo (mammary glands of mouse and cow) 31 
4.3.2 In vitro (murine HC11 and bovine BME-UV mammary        
epithelial cells) 33 
4.4 Effects of cell differentiation, inhibitor and Bcrp RNAi on                 
BCRP-mediated transport (paper I) 35 
4.5 Effects of prochloraz on gene expression and function                            
of transporters (paper II) 36 
4.5.1 Gene expression 36 
4.5.2 Function 38 
5 Conclusions 41 
6 Future Perspectives 43 
References 45 
Acknowledgements 55 
 
 
7 
List of Publications 
This thesis is based on the work contained in the following papers, referred to 
by Roman numerals in the text: 
I Jonas Tallkvist, Yagmur Yagdiran, Louise Danielsson, Agneta Oskarsson 
(2015). A Model of Secreting Murine Mammary Epithelial HC11 Cells 
Comprising Endogenous Bcrp/Abcg2 Expression and Function. Cell Biol 
Toxicol, 31 (2), pp. 111-120 
II Yagmur Yagdiran, Agneta Oskarsson, Christopher H. Knight, Jonas 
Tallkvist. ABC- and SLC- Transporters in Murine and Bovine Mammary 
Epithelium - Effects of Prochloraz. (Manuscript).  
Paper I is reproduced with the permission of the publisher. 
8 
The contribution of Yagmur Yagdiran to the papers included in this thesis was 
as follows: 
I Participated in designing the experiments and performed the main part of 
the practical work, compiled and analysed the data. Contributed to the 
writing and publishing of the paper. 
II Contributed to the planning of the work. Performed the experiments, 
compiled and analysed the data. Major contribution to the writing of the 
manuscript. 
 
  
9 
Abbreviations 
  
ABC ATP-binding cassette 
ATP Adenosine triphosphate 
BCA Bicinchoninic acid assay 
BCRP Breast cancer resistance protein (ABCG2) 
BME-UV 
cells 
Bovine mammary epithelial cell line established at the University 
of Vermont 
cDNA Complementary DNA 
CLDs Protein-coated cytoplasmic lipid droplets 
Ct Threshold cycle 
DMSO Dimethyl sulfoxide 
EFSA European Food Safety Authority 
EGF Epidermal growth factor  
FBS Fetal bovine serum 
GF120918 Elacridar 
Ham’s F12 Nutrient mixture 
HBSS Hanks' Balanced Salt Solution 
HC11 
cells 
Murine mammary epithelial cells 
HUGO Human genome organization 
JAK2 Janus kinase 2 
LD Lactation day 
LDH Lactate dehydrogenase 
M/P ratio Milk to plasma ratio 
MDR1 Multidrug resistance protein 1 
mRNA Messenger ribonucleic acid 
MRP1 Multidrug resistance-associated protein 1 
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2Htetrazolium) 
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MX Mitoxantrone 
NBD Nucleotide binding domain 
NCTC 
135 
Nutrient mixture 
OATP1A2 Solute carrier organic anion transporter family member 1A2 
(SLCO1A2/OATP-A) 
Oatp1a5 Solute carrier organic anion transporter family, member 1a5 
(Slca1a5/Oatp3) 
OCT1 solute carrier family 22 (organic cation transporter), member 1 
(SLC22A1) 
OCTN1 solute carrier family 22 (organic cation/zwitterion transporter), 
member 4 (SLC22A4) 
P-gp Permeability glycoprotein (MDR1/ABCB1) 
PhIP 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine 
PRL Prolactin 
PRLR Prolactin receptor 
Prochloraz N-Propyl-N-(2-(2,4,6-trichlorphenoxy)ethyl)-1H-imidazol-1-
carboxamid 
RIPA 
buffer 
Radioimmunoprecipitation assay buffer 
RNAi RNA interference 
RPMI Roswell Park Memorial Institute medium 
SDS-
PAGE 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
siRNA Small interfering RNA 
SLC Solute carrier 
Stat5 Signal Transducer and Activator of Transcription 5 
SYBR 
green 
An asymmetrical cyanine dye used as nucleic stain 
T3 Triiodothyronine 
T4 Thyroxine 
TMD Transmembrane domain 
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1 Introduction 
 
1.1 Milk and environmental toxicants 
Breast milk is a valuable nutritional source for normal growth and development 
by providing macronutrients (sugar, fat and protein) and micronutrients 
(vitamins, minerals and growth factors) to the suckling infant (Pereira, 2014; 
Warinner et al., 2014; Haug et al., 2007).  Nevertheless, it should be noted that 
milk could also be a source of chemical compounds, which may have adverse 
health effects in the breastfed infant (Ito & Lee, 2003; McManaman & Neville, 
2003; Hallen et al., 1998; Oskarsson et al., 1998; Oskarsson et al., 1995).  
The consumption of milk and dairy products is very high and contaminants 
in cow’s milk may cause important health problems for the population. Besides 
the drugs that are administered to lactating dairy cattle, these animals may also 
be exposed to organic pollutants, pesticides and/or mycotoxins through feed 
and soil. Excretion of toxicants in milk has been reported in several studies 
(Tornkvist et al., 2011; Meucci et al., 2010; Darnerud et al., 2006; Schaum et 
al., 2003). Atmospheric deposition of environmental pollutants and use of 
pesticides in agriculture allows grazing cows to ingest contaminated grass or 
hay and silage. Lipophilic properties of these toxicants lead them to distribute 
into fat tissues in the body including the milk fat of a lactating cow. 
Consequently, milk serves an efficient elimination pathway for these 
contaminants (Schmid et al., 2003). The high consumption of milk and dairy 
products means that even low concentrations of toxic compounds may result in 
a relatively high oral intake. 
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1.2 Mammary gland as a secretory organ 
The mammary gland development from a virgin to a milk secreting stage is 
stimulated by a combined action of reproductive (estrogen, progesterone and 
prolactin) and metabolic hormones (insulin, glucocorticoids and growth 
hormones) causing changes in the cellular composition of the mammary gland 
as well as the structural and biochemical properties of the milk synthesizing 
mammary epithelial cells (Neville et al., 2002).   
Mammary epithelial cells form a polarized single cell layer in the alveoli of 
lactating mammary gland (Figure 1A-B). These cells are minor units of a 
branching network of ducts and responsible for the secretion of several milk 
components into the lumen where the milk is stored (Figure 1B) (Richert et al., 
2000). Myoepithelial cells discontinuously surround the alveoli and establish 
direct contact with the basement membrane (Figure 1B). Milk ejection through 
the ducts is accomplished by contraction of myoepithelial cells by the action of 
oxytocin which is released into the systemic circulation as a result of nipple 
stimulation. The alveoli of the lactating gland are also surrounded with a 
vascularized connective tissue stroma that is composed of lipid-depleted 
adipocytes and fibroblasts (Figure 1B) (McManaman & Neville, 2003; Richert 
et al., 2000). At the end of lactation, mammary gland undergoes involution 
where this secretary organ returns to the pre-pregnant stage (McManaman & 
Neville, 2003; Richert et al., 2000). 
1.3 Passive and active transport by several transport pathways 
1.3.1 Secretion routes 
Well-organized mechanisms act in concert to deliver essential nutrients from 
the blood side across mammary epithelial cells followed by its release into 
milk, and non-nutritional compounds may utilize same mechanisms to enter 
milk. Thus, different secretory transport pathways may be responsible for the 
presence of drugs and other xenobiotics in milk. 
Endogenous substances like major milk proteins, lactose, oligosaccharides, 
citrate, phosphate and calcium are transported to milk across the apical 
membranes of alveolar cells via the exocytotic pathway (Figure 1C, III) 
(McManaman & Neville, 2003). Milk fat globules originating from triglyceride 
and cholesteryl esters are released as protein-coated cytoplasmic lipid droplets 
and secreted into milk via the lipid secretion pathway (Figure 1C, II) which is a 
process unique to mammary epithelial cells (Russell et al., 2007) 
Macromolecular substances such as immunoglobulins, albumin and transferrin 
enter milk via transcytotic pathway (Figure 1C, V). Active transport requires 
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the presence of specific transport proteins in both apical and basolateral 
membranes of epithelial cells. Small molecules including ions, amino acids and 
glucose are actively transported into milk via this protein-mediated pathway 
(Figure 1C, I). Toxic compounds may also cross the lactating mammary 
epithelium via active transport mechanisms (protein-mediated pathway, I) or 
via passive transcellular diffusion of lipohilic compounds (transcytotic 
pathway, V). If tight junctions are affected xenobiotics may enter milk 
passively (paracellular pathway, IV). 
The present study will focus on the details of active transport and the 
transporters during lactation (Figure 1C, protein-mediated pathway, I). Many 
of the transport proteins comprising this pathway feature broad substrate 
specificities and may thus actively transport both endogenous and exogenous 
compounds across the lactating mammary epithelium. 
1.3.2 Factors influencing chemical transfer into milk 
Hence, there are two basic mechanisms for secretion of toxic compounds into 
milk. In case of passive diffusion uncharged and lipophilic chemicals are 
secreted into milk until the concentration of the residues reaches equilibrium 
between plasma and milk. The amount of residues present in milk can be 
predicted by molecular size of the chemical, lipophilicity, plasma protein 
binding and pKa (Fleishaker, 2003; Agatonovic-Kustrin et al., 2002).  
Calculation of the ratio between the concentrations of chemicals in milk and 
in plasma (M/P ratio) over time is used to assess participation of passive or 
active processes. In the case of passive diffusion the M/P ratio is ≤ 1 and in 
case of active transport M/P ratio is > 1 (Fleishaker, 2003; Ito & Lee, 2003; 
Gerk et al., 2001).  
1.4 Transporters 
A large number of membrane transport proteins have been characterized. Two 
major classes are involved in the transfer of drugs and xenobiotics classified as 
the ATP-binding cassette (ABC-) and solute carrier (SLC-) transporters. 
Members of these families are expressed in the apical or basolateral membrane 
of polarized epithelial cells in the intestine, liver, kidney, blood brain barrier, 
placenta as well as mammary gland and play an important role in chemical 
absorption, distribution and elimination in the body (Russel, 2010; Sai & Tsuji, 
2004; Ito & Alcorn, 2003). 
Transport proteins belonging to both the ABC- and SLC- superfamilies are 
expressed at various levels depending on lactation stage of the mammary gland 
(Gilchrist & Alcorn, 2010; Jonker et al., 2005; Alcorn et al., 2002). This 
14 
altered expression allows some of these transporters to deliver vitamins, fatty 
acids, sterols, porphyrins and amino acids to the nursed offspring via milk 
(Vlaming et al., 2009; van Herwaarden et al., 2007; Kwok et al., 2006).  The 
transporters have substrate specificity not only for nutrients but also for drugs 
and xenobiotics which may be actively transported resulting in high 
concentrations in milk (Figure 1C) (Ito et al., 2014; Kindla et al., 2011; 
Gilchrist & Alcorn, 2010; Kwok et al., 2006; Jonker et al., 2005; Ito & Alcorn, 
2003).  
1.4.1 ATP-binding cassette (ABC) transporters 
ABC transporters are membrane proteins consisting of seven subfamilies 
named A to G (Szakacs et al., 2008). Their existence and conserved structure 
across different organisms emphasize the fact that these transporters are 
fundamental for all living systems (Jones & George, 2004). ABC transporters 
function as efflux pumps and are involved in the excretion of chemicals across 
the membranes of epithelial cells against a concentration gradient into the 
bloodstream or a lumen using ATP hydrolysis as energy source (Russel, 2010; 
Couture et al., 2006). ABC transporters generally have the similar conserved 
structure that is composed of transmembrane domains (TMDs) and nucleotide-
binding domains (NBDs) (Szakacs et al., 2008; Chan et al., 2004; Jones & 
George, 2004). Three subfamilies of this family are particularly involved in 
transport of drugs and xenobiotics, which are known as ABCB, ABCC and 
ABCG families.  
Breast cancer resistance protein (BCRP/ABCG2) 
BCRP belongs to the G subfamily of the ABC family. The gene was first 
cloned from a human breast carcinoma cell line in 1998 (Doyle et al., 1998). 
BCRP is a half transporter protein comprised of one NBD and one TMD with 
six transmembrane α-helices. Thus, BCRP is thought to function as a 
homodimer (Jani et al., 2014; Staud & Pavek, 2005; Chan et al., 2004).  BCRP 
is a 72-kDa protein with 665 amino acids (Staud & Pavek, 2005) detected in 
epithelial of numerous normal (non-tumorigenic) tissues such as colon, liver, 
placenta, intestine, mammary glands and many others (Fetsch et al., 2006; 
Alcorn et al., 2002; Maliepaard et al., 2001). From the physiological point of 
view, apical localization of BCRP in the polarized cells exhibits a general 
protective role by reducing the levels of drugs and xenobiotics in the cells by 
active efflux of its substrates (Maliepaard et al., 2001).  
Expression of BCRP is induced in the apical membrane of mammary 
epithelial cells in mammary glands of various species during lactation (Jonker 
et al., 2005). Although, BCRP generally has a protective function in other 
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tissues, the reason for its role in the mammary gland remains unclear. 
However, BCRP has substrate specificity to a number of vitamins including 
vitamin K3 (Shukla et al., 2007), riboflavin (van Herwaarden et al., 2007) and 
folic acid (Assaraf, 2006). Apical expression of BCRP along with the induced 
expression in lactating mammary epithelial cells may suggest a physiological 
role for the secretion of these nutrients into milk during lactation (Lindner et 
al., 2013; van Herwaarden et al., 2007; Alcorn et al., 2002).  
Unfortunately, several drugs and toxins, including topotecan, 2-amino-1-
methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) (Jonker et al., 2005), 
mitoxantrone (Imai et al., 2003; Litman et al., 2000), nitrofurantonin (Merino 
et al., 2005), ciprofloxacin (Merino et al., 2006), and enrofloxacin (Pulido et 
al., 2006), have been identified as BCRP substrates which are transported and 
concentrated in milk by this efflux protein. 
Prochloraz (N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-
carboxamide) is an imidazole fungicide used in agriculture and horticulture 
that may cause a general exposure through consumption of fruit and vegetables 
(EFSA, 2011). Prochloraz is an endocrine disruptor with various modes of 
action (Ohlsson et al., 2009; Vinggaard et al., 2006). Treatment of primary 
bovine mammary epithelial cells with prochloraz resulted in increased BCRP 
expression through AhR activation (Halwachs et al., 2013). 
 
Multi drug resistance protein 1 (MDR1/ABCB1) 
MDR1 (also known as Permeability-glycoprotein or P-gp) was the first cloned 
drug carrier from colchicine-resistant Chinese hamster ovary cells (Juliano & 
Ling, 1976) and is the best characterized protein of the ABC transporter family 
(Silva et al., 2015). The gene encodes a 170-kDa single polypeptide with 1280 
amino acids (Hoffmann & Kroemer, 2004; Leonessa & Clarke, 2003). Similar 
to other ABC family members, MDR1 consists of two TMDs each containing 
six transmembrane helices and two cytoplasmic NBDs (Jones & George, 
2004). 
MDR1 is present with a high expression at the apical surface of the 
epithelial cells in liver, colon, kidney proximal tubules and pancreatic ductules. 
The tissue localization as an efflux transporter in excretory organs, suggest that 
MDR1 plays a role in the protection of the organs by effluxing metabolites and 
xenobiotics out of the epithelial cells (Silva et al., 2015).  
Beside these tissues, MDR1 is expressed in mammary glands of mouse, rat 
and human although with lower abundance during lactation (Gilchrist & 
Alcorn, 2010; Jonker et al., 2005; Alcorn et al., 2002). MDR1 has broad 
substrate specificity to hydrophobic neutral or positively charged molecules 
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including anticancer chemotherapeutic reagents and xenobiotics (Ito & Alcorn, 
2003). The physiological role for the decline in expression of MDR1 in the 
apical membranes of secreting mammary epithelial cells remains obscure but 
may reflect an adaptive response to prevent efflux of xenobiotics or drugs into 
milk in order to protect the nursing neonate from exposure (Alcorn et al., 
2002).   
 
Multidrug resistance-associated protein 1 (MRP1/ABCC1) 
MRP1 is one of nine members of ATP-binding cassette C subfamily. It was 
first cloned from a multidrug resistant human small cell lung cancer cell line 
(H69R) that does not express MDR1 (Bakos & Homolya, 2007; Chan et al., 
2004; Cole et al., 1992). MRP1 gene encodes a 190-kDa protein comprising 
1531 amino acids. It features three TMDs instead of two and 17 
transmembrane helices together with two NBDs (Gradhand & Kim, 2008). 
MRP1 is an efflux pump and notably expressed on the basolateral 
membrane of sarcolemma cells in heart, bronchial epithelium cells in lungs, 
Leydig and Sertoli cells in testes, crypt cells in intestine, urinary collecting 
ducts and glomeruli in kidney but also on the apical membrane of endothelial 
cells in placenta and capillary endothelial cells in brain (Klaassen & 
Aleksunes, 2010; Leslie et al., 2005).  Substrates of MRP1 include 
amphipathic compounds and glutathione S-conjugates, oxidized glutathione, 
leukotriene C4 and several cancer chemotherapeutics (Chan et al., 2004). 
Although the subcellular localization of MRP1 has not yet been verified, gene 
and protein expressions have been shown to be down regulated during lactation 
in human mammary epithelial cells as well as in mammary glands of mice and 
rats (Gilchrist & Alcorn, 2010; Jonker et al., 2005; Alcorn et al., 2002).  
1.4.2 Solute Carrier (SLC) Transporters 
The solute carrier transporter family is the largest group of transporters with 
298 members in 43 subfamilies based on HUGO assembly sequences. The 
members are divided based on their function and different biochemical 
properties (Fredriksson et al., 2008). As a result, they can function as coupled 
transporters, exchangers/antiporters related with cellular sodium gradient and 
as passive or active transporters (Fredriksson et al., 2008). Unlike the ATP 
family, members of the SLC family use secondary and tertiary active transport 
typically in the uptake (influx) or bidirectional transport of chemicals across 
biological membranes (Klaassen & Aleksunes, 2010). To assure the driving 
force by secondary active transport against a diffusion gradient, there should be 
a connection to the symport or antiport of inorganic or organic ions. Most of 
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the proteins in the family generally have the similar structure with 12 putative 
transmembrane domains and have molecular sizes between 50-100-kDa 
(Russel, 2010). Localization of these transporters can be either apical or 
basolateral depending on the tissue and cell type (Roth et al., 2012). 
In the present study we will focus on some representative transporters from 
three different subfamilies including the organic anion organic polypeptide 
(SLCO), organic cation transporter (SLC47) and organic cation/carnitine 
transporter (SLC22) families.  
Solute carrier organic anion transporter family member 1A2 
(OATP1A2/SLCO1A2) 
OATP1A2 is a member of SLCO family and it was isolated by hybridization 
screening from human liver as the first human superfamily member 
(Hagenbuch & Meier, 2003). Radiation hybrid analysis and fluorescent in situ 
hybridization have demonstrated that the human OATP1A2 gene [previously 
called OATP-A (Hagenbuch & Meier, 2004)] is localized to chromosome 12. 
These studies also showed that OATP1A2 is the human orthologue of mouse 
Oatp1a5 [previously called Oatp3 (Hagenbuch & Meier, 2004)] High degree of 
identity (72%) supported this argument when OATP1A2 and Oatp1a5 amino 
acid sequences were aligned (Walters et al., 2000).  
OATP1A2 is an influx transporter that functions in a Na+ independent 
manner. This transporter has broad substrate specificity particularly to anionic 
compounds (Arakawa et al., 2012).  Human OATP1A2 is apically localized on 
cholangiocytes in liver, enterocytes in small intestine, and distal tubules in 
kidney. Mouse and rat Oatp1a5 also have apical localization in epithelial cells 
of choroid plexus, endothelial cells of and brain and enterocytes of jejunum, 
respectively (Klaassen & Aleksunes, 2010).  
Expression of OATP1A2 (OATP-A) was detected in human mammary 
epithelial cells and transcript levels demonstrated to be upregulated during 
lactation (Alcorn et al., 2002). OATP1A2 (Oatp1a5) has a significant role in 
non-tumorigenic tissues by mediating the transport of endogenous substrates 
such as conjugated and free bile salts, thyroid hormones (T3 and T4), steroids 
and steroid conjugates. Similar to other transporters OATP1A2 has also 
substrate specificity to exogenous compounds and drugs including 
erythromycin and imatinib (Liu & Li, 2014; Kalliokoski & Niemi, 2009; Ito & 
Alcorn, 2003). The physiological role for OATP1A2 induction in the lactating 
mammary gland remains unclear but may suggest a contribution to organic 
anion transfer in mammary epithelium resulting in an accumulation of this type 
of compounds in milk.  
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Organic cation transporter 1 (OCT1/SLC22A1) 
OCT1 was found as a first member of organic cation transporter family that 
was cloned from a rat kidney cDNA library (Grundemann et al., 1994). Shortly 
after, its mouse and human orthologues were also cloned (Klaassen & 
Aleksunes, 2010).  Human OCT1 mRNA is predominantly expressed in liver 
compared to other organs whereas high abundances for the murine orthologue 
Oct1 was observed in both liver and kidneys (Koepsell, 2013; Klaassen & 
Aleksunes, 2010; Koepsell & Endou, 2004). OCT1 is also induced during 
lactation in mammary glands of mouse, rat and human (Ito et al., 2014; 
Gilchrist & Alcorn, 2010; Alcorn et al., 2002). Cellular localization of the 
protein can differ depending on the tissue and species. Oct1 proteins have been 
reported to be localized to the basolateral membrane of proximal tubules in rat 
kidney while others have reported localization of OCT1 in the apical 
membranes of proximal and distal tubules in humans (Koepsell, 2013; 
Klaassen & Aleksunes, 2010; Koepsell & Endou, 2004). OCT1 mediates 
transport of organic cations that are positively charged at physiological pH. 
This transport functions in an electrogenic manner that is independent from 
sodium. The substrate list for OCT1 is wide and include many endogenous 
compounds such as neuromodulators cyclo (His-Pro), prostaglandins, 
salsolinol and metabolites like putrescine and agmatine and drugs such as 
antiparkinsonians, antidiabetics, some carcinogen toxins like aflatoxin B1 and 
ethidiumbromide (Koepsell, 2013; Jonker & Schinkel, 2004; Sai & Tsuji, 
2004).  
In general, OCT1 has roles in the hepatic excretion of cationic drugs, 
reabsorption of ultra-filtrated cations in kidney, the absoption of drugs in lungs 
and also passage of endogenous substrates of drugs across blood-brain barrier 
(Koepsell, 2013).  
The exact membrane localization of OCT1 in mammary gland remains to 
be elucidated. Therefore, it is difficult to make interpretation about its 
physiological roles in lactating mammary gland. However, secretion of 
important nutrients into milk such as thiamine (vitamin B1) may suggest one of 
the possible role of OCT1 (Ito et al., 2014). Furthermore, prostaglandins which 
are substrates of OCT1 are found in human milk that may be in relation to the 
protective role of milk lipids (Lucas & Mitchell, 1980). In addition, 
cooperative vectorial transport of cimetidine and acyclovir into milk, which are 
substrates for both Bcrp and Oct1, suggested that Oct1 probably expressed on 
the basolateral side of the membrane in mouse mammary epithelial cells. Oct1 
exhibits substrate uptake from blood into the cell while Bcrp permits substrate 
secretion from cell into the milk (Ito et al., 2014).  
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Organic cation transporter novel protein type1 (OCTN1/SLC22A4)  
OCTN1 is encoded by SLC22A4 gene, which was cloned from human fetal 
kidney (Tamai et al., 1997). OCTN1 is expressed in different tissues such as 
intestine, liver, kidney, brain, heart, skeletal muscle and mammary gland of 
mouse, rat and human (Koepsell, 2013; Gilchrist & Alcorn, 2010; Alcorn et al., 
2002). Immunohistochemical studies revealed that Octn1 is predominantly 
localized in the blood vessel endothelium and in the apical membranes of 
secretory mammary cells in rat mammary glands (Lamhonwah et al., 2011). A 
recent study has also demonstrated that OCTN1 is localized within the 
mitochondrial cells suggesting a possible mechanism required for carnitine 
transport into the organelle (Lamhonwah & Tein, 2006).  
OCTN1 has been shown as multi-specific, bidirectional, pH dependent 
transporter (Yabuuchi et al., 1999) therefore it may undertake different roles in 
the plasma membranes as cation exchanger, as sodium dependent or 
independent transporter for zwitterions and as organic cation/proton exchanger 
that exhibits crucial functions for the system (Koepsell, 2013). Similar to other 
transporters reviewed above, OCTN1 also has substrate specificity to 
endogenous compounds as well as drugs and xenobiotics. Among all these, the 
most prominent substrates are zwitterions that include L-carnitine. It is a small 
water-soluble compound has critical physiological roles as a cofactor that 
involves in the β-oxidation of long chain fatty acids and glucose oxidation in 
the muscle and heart for ATP generation (Lamhonwah et al., 2011). 
Octn1/OCTN1 gene and protein expression have been demonstrated to be up 
regulated during lactation in mammary gland of rats and in human mammary 
epithelial cells (Lamhonwah et al., 2011; Gilchrist & Alcorn, 2010; Ling & 
Alcorn, 2010; Alcorn et al., 2002). L-carnitine, which is essential for early 
brain growth and development of the physiologically immature infant, is not 
synthesized endogenously and delivery is maintained by protein-mediated 
transport into milk.  
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Figure 1. A schematic illustration of a mammary gland at lactating stage (A). Mammary alveolus 
consists of different cell types. Mammary epithelial cells are surrounded by myoepithelial cells 
that play an important role in ejection of milk into the ductal lumen (B). Transport pathways that 
occur in the mammary epithelial cells. *I: Protein-mediated transport pathway; II: Lipid secretion 
pathway; III: Exocytotic pathway; IV: Paracellular pathway; V: Transcytotic pathway (C). 
*Active transport of chemical compounds via the protein mediated pathway is carried out by 
transport proteins that belong to ABC and SLC superfamilies. Cellular localizations of the 
transporters shown in the figure with (?) are predictions based on localizations previously 
demonstrated in other tissues.    
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1.5 Murine (HC11) and bovine (BME-UV) mammary epithelial 
cell lines as in vitro models  
Polarized cell lines without recombinant genes and proteins allow us to study 
endogenous transport mechanisms. Therefore, the cell lines chosen for 
studying these processes must exhibit functional and morphological properties 
similar to in vivo cell layers in order to make correlations. Consequently, these 
models can be applied as tools to gain knowledge regarding function of 
transport mechanisms where the findings may be extrapolated to humans.  
HC11 cells are derived from mammary glands of BALB/c mice during mid-
pregnancy (Danielson et al., 1984). This cell line is the first clone of non-
tumorigenic COMMA-1D cells that take on a secreting phenotype upon 
prolactin treatment resembling mammary epithelial cells in the lactating 
mammary gland. β-casein induction is accomplished in the presence of 
lactogenic hormones especially by prolactin without any requirement for an 
extracellular matrix or co-cultivation with adipocytes and/or fibroblasts (Ball et 
al., 1988).  
BME-UV cells are non-tumorigenic mammary epithelial cells originating 
from mammary gland tissue of a lactating and pregnant Holstein cow. Optimal 
conditions for casein synthesis for the BME-UV cells have not yet been 
established. However, there is evidence that BME-UV cells are producing low 
levels of αs1-casein and k-casein and displaying some of the important 
functions of mammary epithelial cells (Zavizion et al., 1996). 
Morphological and functional changes in mammary epithelial cells in vitro 
are regulated with signalling pathways (Groner & Gouilleux, 1995). These 
pathways are synergistically regulated by different hormones including 
epidermal growth factor (EGF), insulin, prolactin (PRL) and glucocorticoids 
(Pauloin & Chanat, 2012; Shan et al., 2008). In the presence of insulin and 
EGF, mammary epithelial cells grown to confluency, become competent and 
ready to respond to lactogenic hormones (Shan et al., 2008). The initial step in 
the mechanism of action of PRL starts when it binds to the cell surface 
receptor, prolactin receptor (PRLR). This coupling causes ligand-induced 
dimerization and leads to phosphorylation and activation of JAK2 (Januse) 
kinases. Subsequently, this induces phosphorylation of the tyrosine residues in 
the C-terminal tail of the prolactin receptor. As a result, it creates specific 
domains for proteins like signal transducer and activator of transcription 5 
protein (Stat5), which is capable of, translocate to nucleus. Transcription of 
genes that code for milk proteins starts when activated Stat5 dimers bind to 
certain specific sites on their promoter region (Bole-Feysot et al., 1998; Groner 
& Gouilleux, 1995). 
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The synergistic effect of glucocorticoids with insulin and prolactin 
regarding differentiation should be also taken into consideration (Desrivieres et 
al., 2007). Physical interaction of glucocorticoid receptor with Stat 5 upon 
glucocorticoid binding assists the ability of Stat5 to activate -casein 
transcription (Desrivieres et al., 2007). In addition, it has been shown that 
induction of genes that code milk proteins failed when one of these hormones 
eliminated (Pauloin & Chanat, 2012; Desrivieres et al., 2007; Stocklin et al., 
1996). 
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2 Aims of the thesis 
The overall aims of thesis were to determine expressions of ABC- and SLC- 
transporters in mammary gland tissue and to assess whether the HC11 and 
BME-UV mammary cell models can be applied to determine substrates, 
inducers and inhibitors of transporters expressed in the mammary epithelium 
during lactation. 
  
More specific aims were to: 
 
1. Investigate gene expressions of endogenous Bcrp, Mdr1, Mrp1, 
Oatp1a5, Octn1 and Oct1 in mammary glands of mice in virgins and at 
various gestation and lactation stages and BCRP, MDR1, MRP1, 
OATP1A2 and OCTN1 in mammary glands of lactating cows. 
 
2. Examine gene expressions and function of transporters in HC11 cells 
with a secretion phenotype and BME-UV cells derived from a lactating 
cow. 
 
3. Assess the effect of prochloraz on gene expression and function of 
transporters in the HC11 and BME-UV cell models. 
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3 Materials and Methods 
The materials and methods used in this thesis are described and presented in 
detail in each paper. The following is a short overview of the methods 
compiled from paper I and paper II.  
3.1 Chemicals 
All chemicals used were of analytical grade and purchased from regular 
commercial sources. Detailed information on chemicals and the commercial 
sources of reagents are presented in the papers.  
3.2 Experimental models 
3.2.1 Mice 
Mammary gland tissues of mice were either used to test the specificity of 
primers for the real-time RT-PCR with cellular RNA and to examine mRNA 
expression levels of transporters at different lactation stages.  
Litter sizes were normalized to ten on lactation day (LD) 1 and the dams 
with litters were kept in individual cages (the day of parturition = LD 0). On 
these respective days of pregnancy (gestational day 13 and18), lactation (day 2 
and 9), involution (weaning day 2) or virgin animals were killed by cervical 
dislocation and mammary glands were rapidly dissected and stored in 
RNAlater solution at -70°C until total RNA extraction.  All animal experiments 
were approved by a Local Ethics Committee of Animal Research (permit no. 
2012-15-2934-00587). 
3.2.2 The HC11 murine mammary epithelial cells (papers I and II) 
HC11 cells were maintained in RPMI 1640 medium containing insulin, fetal 
bovine serum (FBS), epidermal growth factor (EGF) and gentamycin in an 
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atmosphere of 95% air and 5% CO2 in 95% relative humidity.  The cell culture 
medium was changed every 2-3 days and cells sub-cultured when they reached 
80-90% confluency. To induce lactogenic differentiation, medium was 
replaced with differentiation medium supplemented with prolactin and 
hydrocortisone (EGF and FBS free) and incubated for additional 72 h. 
3.2.3 The BME-UV bovine mammary epithelial cells (paper II) 
Cells were maintained in sterile filtered RPMI 1640 medium supplemented 
with FBS, Ham’s F12, NCTC 135, lactose, lactalbumin hydrolysate, GSH, L 
ascorbic acid, hydrocortisone, insulin and gentamycin in polycarbonate flasks 
at 37°C in a humidified 5% CO2 incubator until confluence as described 
(Zavizion et al., 1996). Prolactin was added to the cells 72 h prior to isolation 
of RNA for gene expression measurements or transport experiments as 
described (Liu et al., 2006). 
3.3 Experimental Techniques 
3.3.1 Cellular organization of HC11 cells (paper I) 
Cells were seeded on a chamber slide and grown until confluence. Chambers 
covering half of the slide were used for undifferentiated HC11 cells (controls) 
while the cells in other half were differentiated as described above. 
Subsequently, cells were fixed with refrigerated acetone and stained with 
hematoxylin in order to examine cellular organization under microscope.   
3.3.2 Histological characterization of mammary gland tissues of mice 
Samples of the mammary glands for histology were fixed in 4% 
paraformaldehyde and dehydrated in ethanol saline buffer. Tissues were 
imbedded in paraffin and sections were stained with hematoxylin and eosin. 
3.3.3 Cytotoxicity 
Cytotoxicity was measured by MTS test that was carried out according to the 
instructions of the manufacturer (Promega).  
3.3.4 Gene expression 
The quantitative gene expression of the murine and bovine β-casein, Bcrp, 
Mdr1, Mrp1, Oatp1A2/1a5, Octn1, Oct1 and murine Cyclophilin B was 
measured by real time RT-PCR on a RotorGene 3000 using the One-tube 
QuantiTect™ SYBR®Green RT-PCR kit according to the manufacturer’s 
instructions (for details, see papers I and II). The primers used, which were 
specific for both murine and bovine mRNA, are presented in Table 1 (papers I 
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and II). Gene expressions were normalized to total RNA and relative 
quantifications of normalized gene expressions were performed by comparing 
the threshold cycles (Ct) of untreated and treated samples according to the 2
-ΔCt
 
method (Livak & Schmittgen, 2001). Fold differences were calculated setting 
untreated controls to one.  
3.3.5 Protein expression  
Protein expressions of drug transporters in the murine mammary epithelial 
cells (HC11) were quantified by Western blot. HC11 cells and mammary gland 
tissues were homogenized in RIPA-lysis buffer and total protein concentrations 
were quantified using the bicinchoninic acid (BCA) protein assay. Cellular 
proteins were separated by SDS-PAGE and blotted on to nitrocellulose 
membranes prior to blocking and antibody (Bcrp and Mdr1) hybridizations (for 
detail, see paper I). Intensities of obtained bands were quantified by the 
OptiQuant software using a ChemiDoc instrument (BioRad). In the analyses 
expression of target proteins was normalized to protein expression of tubulin.   
3.3.6 Gene silencing by small interfering RNAs (paper I) 
RNA interference (RNAi) is a process where target genes are silenced in a 
sequence specific manner with short interfering RNAs (siRNA) (Dykxhoorn et 
al., 2003). 
We first optimized transfection efficiency conditions in HC11 cells by 
testing various cell densities and dilutions of transfection reagents. 
Optimization was accomplished using the housekeeping gene cyclophilin B. 
Following gene silencing, efficient siRNA transfection was verified by 
quantitative real-time RT-PCR with specific primers to cyclophilin B.  Using 
the same protocol with Bcrp siRNA-duplexes Bcrp-transcript levels were 
reduced to the same extent as cyclophilin B. 
3.3.7 Transport Experiments (papers I and II) 
For both accumulation and secretion studies, HC11 and BME-UV cells were 
seeded in 12 well plates, cultured and treated as described above. Mitoxantrone 
(MX) or digoxin were used to examine the function of BCRP or MDR1 
respectively in the HC11 and BME-UV using 
3
H-MX or 
3
H-digoxin as tracers. 
Both accumulation and secretion of MX or digoxin were normalized to total 
cellular protein of the HC11 and BME-UV cells (for details, see papers I and 
II).  
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3.4 Statistics 
Non-parametric methods; Kruskal-Wallis and Mann-Whitney Rank-Sum tests 
were used. Data was first analyzed by the Kruskal-Wallis test to detect 
statistical significant differences between experimental groups. Subsequently, 
Mann-Whitney Rank-sum test was applied to demonstrate statistically 
significant differences between pairs of groups. The level of significance was 
set at p≤0.05. All statistical analyses were performed in Statview or MiniTab.  
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4 Results and Discussion 
 
4.1 Histology 
4.1.1  Mammary gland development in mouse (paper II) 
Histological changes in mammary gland of mouse throughout different stages 
are shown in Figure 2B. It is a brief presentation of morphological changes that 
occur during mammary gland development. Prior to pregnancy, mammary 
gland consists mainly of adipose tissue (V). During gestation days 13-18, 
alveolar lobules start to develop and partly fill the fat pad (G13 and G18). The 
epithelial cells are able to produce milk proteins and lipids at gestation day 18 
(arrow, G18). Alveolar lobules turn into secretory structures that are 
surrounded by adipocytes at the beginning of lactation (L2). During peak 
lactation (L9) the mammary gland consists mainly of alveolar structures with 
large and milk filled lumina. At the end of lactation, a remodelling of the 
mammary gland occurs in a process called involution comprising a 
degeneration of alveolar cells and an increase in fat content, typical of non-
lactating mammary glands observed prior to pregnancy (W2).     
Knowledge about mammary gland development may provide insight into its 
histological characteristics during lactation. Thus, morphological differences 
between virgin, pregnant and lactating mammary gland tissues can be used as a 
marker for differentiation of cultured mammary epithelial cells. 
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4.1.2 Cellular organization of HC11 cells (paper I) 
Lactogenic differentiation of the HC11 cells by prolactin and glucocorticoids 
resulted in the following morphological changes (Figure 2A). Undifferentiated 
HC11 cells were organized as a monolayer (Figure 2A, left), while alveolar-
like structures including lumina appeared in the differentiated cells resembling 
the pattern that is observed in the mammary glands in vivo during lactation 
(Figure 2B) (Richert et al., 2000; Burgoyne & Duncan, 1998). 
4.2 Induction of β-casein gene expression (papers I and II) 
Beside the changes in cellular organization by lactogenic stimulation -casein 
gene expression was also induced in the HC11 cells. The relative  -casein 
gene expression was significantly increased 2-fold in the differentiated as 
compared to the undifferentiated HC11 cells (Figure 2C, left). It has previously 
been demonstrated that  -casein responds to prolactin in HC11 cells (Ball et 
al., 1988) and that synthesis occurs in rodent mammary epithelial cells in vivo 
and that the abundance of this milk protein increases during gestation and 
peaks at mid-lactation (McManaman & Neville, 2003; Richert et al., 2000; 
Burgoyne & Duncan, 1998; Robinson et al., 1995). Our results once more 
demonstrated a gradual increase in β-casein expression through gestation days 
13 and 18, which continued at lactation days 2 and 9 (Figure 2C right). 
Compared to the highest level observed at lactation day 9 the expression was 
reduced at weaning day 2 (p=0.05) (Figure 2C, right). Thus, reorganization of 
HC11 cells into alveolar-resembling formations in combination with an 
increased  -casein gene expression by lactogenic stimulation appears to be 
reliable markers of a secreting phenotype.  
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Figure 2. Cellular organization of undifferentiated (left) and differentiated (right) HC11 cells (A). 
Histological characterization and progression of mammary gland differentiation in virgin mice 
(V), during pregnancy (G13 and G18), lactation (L2 and L9) and involution (W2) (B). All 
sections have been stained with hematoxylin and eosin. Magnification 20X. β-casein expression 
in undifferentiated and differentiated murine (HC11) mammary epithelial cells (left) and murine 
mammary gland at various stages (right) (C). Statistically significant differences as compared to 
undifferentiated controls or virgins *p ≤0.05; **p≤0.01. 
 
4.3 Expressions of transporters (papers I and II) 
4.3.1 In vivo (mammary glands of mouse and cow) 
Messenger RNA expression levels of Bcrp, Mdr1, Mrp1, Oatp1a5, Octn1 and 
Oct1 in mammary gland tissues were measured at different stages of gestation 
and lactation of mice by real time RT-PCR (paper II). Expressions were 
normalized to mRNA levels in virgins and presented as fold differences in 
Table 1 (for details, see paper II).  
Our results revealed that all transporters sought were present in the mouse 
mammary glands with different expression patterns. Bcrp expression in the 
mice followed a similar pattern as β-casein expression with a continuous 
increase during gestation and lactation and a relative reduction at weaning day 
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2 compared to lactation day 9 (p=0.05) (Table 1). A gradual decrease in Mdr1 
expression was detected in the mammary gland tissues of mice through 
gestation days 13 and 18 which continued at lactation days 2 and 9 (Table 1). 
At weaning day 2 Mdr1 expression was increased as compared to lactation day 
9 (p=0.05) (Table 1). Gene expression of Mrp1 followed a similar pattern as 
Mdr1 with a successive reduction in transcript levels through gestation and 
lactation and a relative increase at weaning day 2 (Figure 1d). Oatp1a5 gene 
expression started to decrease in mouse mammary gland tissues at late 
gestation and was lowest at lactation day 9 (Table 1). Similar to Oatp1a5, 
mRNA levels of Octn1 mRNA decreased continuously through gestation, 
lactation and weaning. Oct1 expression was increased at gestation and lactation 
and reduced at weaning day 2 (Table 1). 
Table 1. Fold differences in transporter mRNA levels in mammary glands of mice compared to 
virgin (mean of 3-4 mice). 
 
Transporter 
Gene 
Virgin G13 G18 L2 L9 W2 
Bcrp 1 3.47 14.29 23.5 31.01 3.23 
Mdr1 1 0.40 0.23 0.09 0.07 0.18 
Mrp1 1 0.41 0.35 0.08 0.05 0.20 
Oatp1a5 1 1.41 0.37 0.04 0.01 0.02 
Octn1 1 0.51 0.14 0.04 0.03 0.10 
Oct1 1 0.98 1.42 1.69 1.56 0.32 
 
In lactating human mammary epithelial cells OATP1A2 and OCTN1 are 
upregulated (Alcorn et al., 2002). Our results showed that both these SLC 
transporters were expressed in murine mammary epithelial cells but were 
down-regulated in the lactating mammary glands of mice. The reason for this 
discrepancy in expressions is not known. However, possible explanations may 
involve species differences or the fact that mammary gland tissue is comprised 
not only of epithelial cells but also of other cell types such as myoepithelial 
cells and ductal cells which may contribute to this result. Supporting this 
hypothesis, our results with the cultured murine mammary epithelial HC11 
cells showed that mRNA levels of Oatp1a5 were increased and Octn1 
transcript levels not reduced by prolactin induced differentiation. In line with 
previous reports our results demonstrated that both Bcrp and Oct1 were most 
abundant during peak lactation as assessed by the peak in  -casein expression, 
whereas Mdr1 and Mrp1 expressions were reduced at this stage (Table 1) (Ito 
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et al., 2014; Shi et al., 2014; Gilchrist & Alcorn, 2010; Jonker et al., 2005; 
Alcorn et al., 2002; Robinson et al., 1995). 
In bovine mammary gland tissue β-casein, BCRP, MDR1, MRP1, 
OATP1A2 and OCTN1 gene expressions were detected (data not shown). A 
limited number of cows were analysed and no data on expression related to 
various lactation stages is available. However, the results showed that the 
bovine specific primers and RT-PCR method is functional. 
4.3.2 In vitro (murine HC11 and bovine BME-UV mammary epithelial cells) 
In papers I and II, gene expressions of Bcrp, Mdr1, Mrp1, Oatp1a5, Octn1 and 
Oct1 were identified in both undifferentiated and differentiated HC11 cells. 
Statistically significant up-regulation in Oatp1a5 gene expression was observed 
in the differentiated HC11 cells as compared to the undifferentiated controls 
(Figure 3, left). Mdr1 gene expression was statistically significantly reduced in 
the differentiated HC11 cells as compared to the undifferentiated controls 
(Figure 3, left). No significant difference due to differentiation was observed in 
Bcrp, Mrp1, Octn1 and Oct1 gene expressions (Figure 3, left). The reason for 
the lack of induction of Bcrp mRNA in the HC11 cells by lactogenic 
stimulation is unknown. However, one possible explanation may be that the 
HC11 cells originally derive from mammary tissue of BALB/c mice during 
gestation when Bcrp transcript levels are induced to a stage where no further 
increases in gene expression occur (Jonker et al., 2005; Danielson et al., 1984). 
Among the genes examined only MDR1 and MRP1 were detected in the BME-
UV cells (Figure 3, right). No difference was observed in MDR1 or MRP1 
gene expressions after prolactin treatment of the cells (Figure 3, right). 
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Figure 3. Relative gene expressions of transporters in undifferentiated (control) and differentiated 
HC11 cells (left) and prolactin treated BME-UV cells (right). Statistically significant differences 
as compared to controls *p ≤0.05. 
 
In addition to gene expressions, Bcrp- and Mdr1-protein was detected in both 
undifferentiated and differentiated HC11 cells (paper I). Bcrp protein 
expression was up-regulated and Mdr1 protein expression down-regulated in 
the differentiated as compared to the undifferentiated HC11 cells (paper I). 
These results are in line with the in vivo findings that BCRP is up-regulated 
and MDR1 down-regulated of lactating mammary glands of various species 
(Gilchrist & Alcorn, 2010; Jonker et al., 2005; Alcorn et al., 2002) and suggest 
that the HC11 model can be used to both assess function of endogenous Bcrp 
and Mdr1 to detect new substrates as well as inducers and inhibitors of these 
transporters.   
HC11 cells have been used as a model for studies on hormonal regulation of 
mammary epithelial cell differentiation as well as milk protein gene expression 
and secretion (Kabotyanski et al., 2006; Desrivieres et al., 2003; Wartmann et 
al., 1996). Furthermore, HC11 cells have been applied to examine the impact 
of cadmium on lactating mammary cells (Öhrvik et al., 2006) and also to 
characterize some transporters belonging to the Solute Carrier (SLC) family 
and ion channels, which are implicated in the flux of magnesium, zinc, copper 
and calcium across the membranes of the lactating mammary epithelium (Ross 
et al., 2013; McCormick & Kelleher, 2012; Öhrvik et al., 2011; Wolf et al., 
2010; Boyd & Naray-Fejes-Toth, 2007; Kelleher & Lonnerdal, 2006; Kelleher 
& Lonnerdal, 2005). However, the HC11 cell model has not yet been used to 
characterize expression and/or function of ATP Binding Cassette (ABC) 
transporters. The localization of both BCRP and MDR1 in the apical 
membranes of mammary epithelial cells in combination with the promiscuity 
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of these active transporters has risen considerable concern from public health, 
food safety, and regulatory perspectives about the presence of drugs and toxic 
compounds in milk both for breast fed infants as well as for consumers of dairy 
products (Wassermann et al., 2013).     
In paper II we identified gene expressions of Mrp1, Oatp1a5 (the mouse 
orthologue to human and bovine OATP1A2), Octn1 and Oct1 in HC11 cells 
with a secreting phenotype. Conceivably, the HC11 cell model may also be 
applicable to investigate substrates as well as inducers and inhibitors of these 
other ABC and SLC transporters. In the bovine mammary epithelial BME-UV 
cells only MDR1 and MRP1 gene expressions were detected. The lack of 
expressions of BCRP, OATP1A2 and OCTN1 in the BME-UV cells may be 
due to a number of reasons such as loss of transcription factors and selection of 
cells during passages, higher passage numbers or culturing conditions 
(Monzani et al., 2011; Blum et al., 1989; Larson, 1976).  
4.4 Effects of cell differentiation, inhibitor and Bcrp RNAi on 
BCRP-mediated transport (paper I) 
The transport experiments with the BCRP substrate 
3
H-mitoxantrone (MX) 
showed that the accumulation was increased in both undifferentiated and 
differentiated HC11 cells simultaneously incubated with the BCRP inhibitor  
GF120918 (Table 2). Thus, in the presence of the BCRP inhibitor the 
accumulation of MX increased with about 21% in the undifferentiated HC11 
cells and with about 36% in the differentiated ones. Our results also showed 
that the accumulation of MX was higher in the differentiated HC11 cells as 
compared to the undifferentiated controls (Table 2). The presence of the 
inhibitor GF120918 also resulted in a decreased secretion of MX from the 
loaded HC11 cells (Table 2). The secretion of MX was reduced to about 65% 
in the presence of GF120918 in undifferentiated HC11 cells and to about 70% 
in the differentiated ones. The results obtained in the transport experiments 
with 
3
H-MX showed that the accumulation of MX in HC11 cells increased 2-
fold by Bcrp RNAi as compared to the MX accumulation in the mock 
transfected HC11 cells (Table 2). 
Our results showed that the net accumulation of MX was higher in the 
differentiated HC11 cells as compared to the undifferentiated controls despite 
an apparent higher expression of Bcrp. This may, at least in part, be explained 
by a reduced expression of Mdr1. Although MX extrusion is predominantly 
mediated by Bcrp it has been demonstrated that MX can be transported to the 
extracellular compartment by Mdr1 although this transporter harbors less 
substrate specificity for MX than Bcrp and thus requires higher substrate 
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concentrations (Kodaira et al., 2010; Rautio et al., 2006; Ahmed-Belkacem et 
al., 2005). Numerous SLC transporters, comprising both organic cation 
transporters (OCTs) and organic anion polypeptide transporters (OATPs), in 
mammary epithelial cells are affected at the transcriptional level by lactogenic 
stimulation (Gilchrist & Alcorn, 2010; Alcorn & McNamara, 2002) including 
some with potential MX affinity. It may, hence, be possible that the increased 
accumulation of MX in the HC11 cells featuring a secretory phenotype as 
opposed to the undifferentiated ones is not only connected to the reduced 
expression of Mdr1 observed herein, but also to a concerted action of a number 
of other transporters including  Oct or/and Oatp transporters. 
Table 2. Accumulation and secretion of 
3
H-mitoxantrone in undifferentiated, differentiated and 
BCRP siRNA transfected HC11 cells. The data are presented as pmol mitoxantrone/mg cellular 
protein. 
Experimental 
condition 
Accumulation 
Effect of 
GF120918 on 
Accumulation 
Secretion 
Effect of 
GF120918 on 
Secretion 
Undifferentiated 
521 ± 86
a
 
 
- 
63 ± 9
e
 
 
- 
Undifferentiated 
+ GF120918 
631 ± 45
b 
 
121% 41 ± 2
f
 65% 
Differentiated 655 ± 125
c
 - 103 ± 7
g
 - 
Differentiated + 
GF120918 
893 ± 153
d 
136% 71 ± 10
h
 69% 
Undifferentiated 
Mock 
505 ± 30
i
 - - - 
Undifferentiated 
RNAi 
1023 ± 42
j
 - - - 
bc
Statistically significant increased accumulation as compared to a, p≤0.05; 
d
Statistically significant increased accumulation as compared to c, p≤0.01; 
f
Statistically significant decreased secretion as compared to e, p≤0.01; 
g
Statistically significant increased secretion as compared to e, p≤0.01; 
h
Statistically significant decreased secretion as compared to g, p≤0.01 
j
Statistically significant increased accumulation as compared to i, p≤0.01. 
4.5 Effects of prochloraz on gene expression and function of 
transporters (paper II) 
4.5.1 Gene expression 
In the present investigation the imidazole fungicide prochloraz (N-propyl-N-
[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide) used in horti- 
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and agriculture (EFSA, 2011) was chosen as a test compound to examine the 
effect on the transporters expressed in the HC11 and BME-UV cell lines. In 
differentiated HC11 cells, prochloraz treatment at non-cytotoxic concentrations 
resulted in a down regulation of gene expressions for Bcrp, Oatp1a5 and Octn1 
(Figure 4, left). Mdr1 mRNA levels were significantly induced at the two 
highest concentrations of prochloraz (10 and 30µM) (Figure 4, left). No 
statistically significant differences were observed for gene expressions of β-
casein, Mrp1 and Oct1 after prochloraz exposure (Figure 4, left). In BME-UV 
cells, gene expressions of MDR1 and MRP1 were induced at the highest 
concentration of prochloraz (30 µM) (Figure 4, right). 
 
 
Figure 4. Relative gene expression of transporters following prochloraz treatment in 
differentiated HC11 and confluent BME-UV cells. Statistically significant differences as 
compared to controls *p ≤0.05; **p≤0.01; ***p≤0.001. 
Prochloraz has been reported to increase Bcrp expression in primary bovine 
mammary epithelial cells (Halwachs et al., 2013) and is transported to milk 
(Vinggaard et al., 2005). However, in the differentiated HC11 cells prochloraz 
did not induce, but rather reduced Bcrp expression. Causes for this discrepancy 
can only be speculated upon but may depend on differences in experimental 
conditions such as prochloraz concentrations used, exposure times, or species 
differences in the display of transcription factors and regulation in BCRP gene 
expression. It can be noted that (Tan et al., 2010) reported that TCDD 
treatment resulted in induction of human but not murine BCRP transcripts. 
Interestingly, the results obtained in the present study showed that 
prochloraz induced gene expression of Mdr1 and MDR1 in both differentiated 
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HC11 and BME-UV cells, respectively. In addition, MRP1 expression was 
upregulated by prochloraz in BME-UV cells. Based on predominant 
expressions of MDR1 and MRP1 in excretory organs which have roles in 
elimination of drugs and xenobiotics; one possible explanation can be that both 
MDR1 and MRP1 undertake protective roles as efflux pumps in order to 
prevent accumulation of chemicals and toxic effects in the cells. The 
localization and induction of MDR1 in the apical membranes of mammary 
epithelial cells may consequently result in an active transport of toxic 
compounds into milk. It has been shown that digoxin is a MDR1 substrate 
(Taipalensuu et al., 2004).  
4.5.2 Function  
Differentiated HC11 and confluent BME-UV cells were exposed to 30 µM 
prochloraz for 24h as described above and the function of MDR1 was studied 
using digoxin as a substrate. Accumulation of digoxin was significantly 
reduced in prochloraz treated HC11 cells compared to the controls cells. Also 
in BME-UV cells a lower, although not statistically significant, accumulation 
of digoxin was observed after prochloraz treatment (Figure 5). 
 
 
Figure 5. The accumulation of 
3
H-digoxin in differentiated HC11 and confluent BME-UV cells, 
treated with 30 uM prochloraz for 24h as described in Paper II. Statistically significant differences 
as compared to controls *p ≤0.05. 
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The increased MDR1 expression in prochloraz exposed mammary epithelial 
cells demonstrates that chemicals may disrupt the expression and function of 
transporters and increase secretion of hazardous chemicals in milk. 
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5 Conclusions 
 
Conclusions from the combined results from papers I and II are:  
 
 
 Gene expressions of ABC- and SLC- transporters differ at various stages of 
mammary gland development and probably reflect the physiological role of 
these proteins in the delivery of essential nutrients into milk.  
 
 Murine mammary epithelial HC11 cells feature endogenous expressions of 
Bcrp, Mdr1, Mrp1, Oatp1a5, Octn1 and Oct1. Gene expressions of Bcrp, 
Mdr1 and Oatp1a5 in undifferentiated and differentiated murine mammary 
epithelial HC11 cells correlate to expressions in the mammary glands of 
non-lactating and lactating mice. Bovine mammary epithelial BME-UV 
cells feature endogenous expressions of MDR1 and MRP1. 
 
 The imidazole fungicide prochloraz causes an increased secretion of the 
MDR1 substrate digoxin in both differentiated HC11 and in BME-UV cells, 
which can be explained by induced gene expression MDR1.  
 
 The HC11 and BME-UV mammary cell models can be used both to 
examine if chemical compounds are actively transported across the 
mammary epithelium and if they disrupt the normal function of 
transporters. 
 
 The models are valuable tools for identifying substrates, inhibitors and 
inducers of ABC- and SLC- transporters expressed in the mammary 
epithelium during lactation. 
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6 Future Perspectives 
 
 
 In the project we have developed mammary cell models for screening 
substrates, inhibitors and inducers of various ABC- and SLC- transporters 
expressed in the mammary epithelium during lactation. These models could 
be applied in future studies to examine if drugs and other chemicals are 
substrates for any of the ABC- and SLC-transporters which would result in 
high concentrations in milk. In addition, chemical compounds affecting 
expression or function of ABC- and SLC-transporters in the lactating 
mammary tissue may cause changes in the composition of nutrients in milk 
with potential adverse health effects in breastfed infants or dairy consumers.  
 
 The present studies were mainly focused on gene expression of transporters. 
Studies on the protein expressions of transporters in the mammary cell 
models are needed. 
 
 Little is known about localization of the ABC- and SLC-transporters in the 
mammary tissue. To understand the physiological role of transporters in the 
membranes of mammary epithelial cells during lactation studies should be 
performed to localize these transporters in mammary tissue. 
 
 Mastitis and especially subclinical mastitis is a common disease in cows 
caused by bacterial infection. It has been shown that inflammation of 
tissues due to bacterial infection affect expression and function of 
transporters in various cell types. Thus, it would be of interest to apply the 
mammary cell models in infection studies to assess the impact of bacterial 
infection on expression and function of transporters.  
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